Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada's National Pharmacare Program Bad News For Pharma?

Executive Summary

Big changes to Canada's pharmaceutical market could be afoot as the country starts to look at what a National Pharmacare program might look like. Moves to improve access to medicines could mean the demise of private drug plans, which would be bad news for companies.

You may also be interested in...



Canada Edges Closer to National Pharmacare Program

Hotly awaited recommendations on implementing a national pharmacare program in Canada have been published. The report also suggests how to improve Canada’s pricing and reimbursement process.

Ontario Introduces Canada’s First Universal Youth Drug Program

Health authorities in Ontario, Canada, have become the first to offer a universal drug program offering younger patients access to free medicines. The move could be a small step towards eventually establishing a National Pharmacare Program across Canada.

UK: Commercial Framework Sheds Light On Working With NHS And NICE

The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.

Topics

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel